Christina Alm - Concepedia

Author

Christina Alm

Karolinska Institutet

Also Known As

Christina Alm

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet University of Toronto Hospital for Sick Children Universidad de Extremadura Karolinska University Hospital

About

Christina Alm is an author at Karolinska Institutet specializing in medicine, genetics, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.1K
2	Natural Sciences	3	3	1.1K
3	Public Health	1	1	59
4	Social Sciences	1	1	71
5	Biochemistry	1	1	40

Christina Alm

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Global Analysis of mRNA Localization Reveals a Prominent Role in Organizing Cellular Architecture and Function Éric Lécuyer, Hideki Yoshida, Neela Parthasarathy, Cell Systems BiologyMedicineNatural SciencesRna Structure PredictionMrna Localization	2007	992
Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in luman beings Marja‐Liisa Dahl‐Puustinen, Anders Lidén, Christina Alm, Clinical Pharmacology & Therapeutics	1989	165
Haloperidol Disposition Is Dependent on Debrisoquine Hydroxylation Phenotype Adrián LLerena, Christina Alm, Marja‐Liisa Dahl, Therapeutic Drug Monitoring	1992	156
Evaluation of Caffeine as an In Vivo Probe for CYP1A2 Using Measurements in Plasma, Saliva, and Urine Juan Antonio Carrillo, Magnus Christensen, Sara Ramos, Therapeutic Drug Monitoring	2000	146
Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity* Juan Antonio Carrillo, Marja-Liisa Dahl, Jan‐Olof Svensson, Clinical Pharmacology & Therapeutics	1996	119
S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin Emílio J. Sanz, Tomás Villén, Christina Alm, Clinical Pharmacology & Therapeutics	1989	115
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype* Karin Herrlin, Amos Massele, Mary Jande, Clinical Pharmacology & Therapeutics	1998	94
Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors* Eva Arlander, Gunilla Ekström, Christina Alm, Clinical Pharmacology & Therapeutics	1998	72
Hippocampal volumes differ across the mouse estrous cycle, can change within 24hours, and associate with cognitive strategies Lily R. Qiu, Jürgen Germann, Shoshana Spring, NeuroImage Synaptic PlasticityCognitive ScienceBrain FunctionDevelopmental Cognitive NeuroscienceMouse Estrous Cycle	2013	71
Systemic Absorption and Block after Epidural Injection of Ropivacaine in Healthy Volunteers Britt-Marie K. Emanuelsson, Jan Persson, Christina Alm, Anesthesiology	1997	69

Page 1